Sort
21,453 grants matching “tuberculosis”
RP3: Targeting ATG gene-dependent immunity for novel anti-infective therapeutics
$1,177,671Seungmin Hwang · Ut Southwestern Medical Center · U19 · FY2021 · AI
Immunogenetic predictors of active and incipient TB in HIV-negative and -positive close TB contacts
$1,177,109Timothy R Sterling · Vanderbilt University Medical Center · R01 · FY2022 · AI
COLUMBIA-ADARC AIDS CLINICAL TRIALS UNIT
$1,176,475Columbia University Health Sciences · U01 · FY2000 · AI
TUBERCULOSIS CONTROL AND ELIMINATION IN THE CITY OF CHICAGO
$1,176,285Kathleen A Ritger · Chicago Department Of Public Health · U52 · FY2014 · PS
Tuberculosis Surveillance, Prevention and Control, and Laboratory Upgrade
$1,174,948Maureen E Murphy · Ohio State Department Of Health · U52 · FY2011 · PS
Infectiousness and social mixing in asymptomatic TB as a driver of population-level transmission
$1,173,748Nippie Sarita Shah · Emory University · R01 · FY2025 · AI
Chemically Modified Peptide Nucleic Acids
$1,173,550Daniel H Appella · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2014 · DK
Immune Regulation in Mycobacterial and Fungal Infections
$1,173,111Daniel Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
PS05-003 TUBERCULOSIS ELIMINATION AND LABORATORY
$1,172,939Angelito Bravo · Arizona State Department Of Hlth Srvcs · U52 · FY2008 · PS
Chemical Biological Discovery of Lipid Virulence Factors in the Major Bacterial Pathogens
$1,172,914David Branch Moody · Brigham And Women'S Hospital · R01 · FY2025 · AI
Predicting immune responses that correlate with protection against tuberculosis
$1,172,751Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · HL
Development and Support of the Pathway Tools Software
$1,172,505Peter D Karp · Sri International · R01 · FY2021 · AI
PS05-003 TUBERCULOSIS ELIMINATION AND LABORATORY
$1,171,614Angelito Bravo · Arizona State Department Of Hlth Srvcs · U52 · FY2009 · PS
Adjuvant Development in the context of a vaccine to protect against tuberculosis
$1,170,507Nikolai Petrovsky · Vaxine Pty Ltd · N01 · FY2021 · AI
Development and Support of the Pathway Tools Software
$1,170,230Peter D Karp · Sri International · R01 · FY2022 · AI
Tuberculosis Elimination
$1,169,106Jon Warkentin · Tennessee State Department Of Health · U52 · FY2015 · PS
Genes And Gene Products As Immunoadjuvants
$1,168,549Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
TB Surrogate Markers for Assessing Reponse to Treatment (TB SMART Study)
$1,167,864Payam Nahid · University Of California, San Francisco · R01 · FY2014 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY COOPERATIVE AGREEMENT
$1,167,406Mary McIntyre · Alabama State Dept Of Public Health · U52 · FY2015 · PS
Miami Treatment and Prevention Clinical Trials Unit (CTU)
$1,166,422Margaret A Fischl · University Of Miami School Of Medicine · UM1 · FY2017 · AI
Immunoregulation /Immune Recognition In Filarial/Nonfilarial Parasitic Infection
$1,165,642Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Production of Pedigreed SPF Rhesus Macaques
$1,164,674Jeffrey A Roberts · University Of California At Davis · U42 · FY2020 · OD
Kaiser Washington Vaccine and Treatment Evaluation Unit
$1,164,520Lisa A Jackson · Kaiser Foundation Research Institute · UM1 · FY2021 · AI
Systems Biology
$1,164,123Rafick-Pierre Sekaly · Beth Israel Deaconess Medical Center · U19 · FY2012 · AI
Task A12 Small Animal Models for Testing of Products Against Mycobacteria
$1,163,838 · N01 · FY2010 · AI